An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)
Clinical trial NCT02962648 · COMPLETED
Trial details
- NCT number
- NCT02962648
- Sponsor
- Pharmacosmos A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-09
- Primary completion
- 2018-06-12
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.